Adia Med Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Larry Powalisz
- Full Time Employees
- 3
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 1561 West Fairbanks Avenue Winter Park FL United States of America 32789
- IPO Date
- Apr 11, 2012
- CIK
- 0001160420
- Website
- adianutrition.com
- Similar Companies
- Business
- Adia Nutrition, Inc. (OTCQB: ADIA) develops and markets nutritional supplements and advanced medical treatments focused on regenerative healthcare and wellness. The company operates through a supplement division offering premium probiotic drink mixes including balanced berry, unsweetened green tea, raspberry lemonade slim, lemon lime sport, and orange mango flavors; probiotic chews in berry and lemonade varieties; and functional beverages such as Biolete protein coffee infused with adaptogens and mushrooms like Cordyceps, Reishi, Lion's Mane, Shiitake, and Turkey Tail for energy, focus, mood enhancement, muscle recovery, and anti-inflammatory benefits; and a medical division providing autologous hematopoietic stem cell transplantation (aHSCT) for multiple sclerosis, therapeutic plasma exchange (TPE), stem cell therapies, platelet-rich plasma (PRP) injections, orthopedic and pain management services, and wound repair through Adia Med clinics. Products are sold online, through nutrition stores, and via AdiaVita and AdiaLink branded HCT/Ps; services target consumers, healthcare providers, and patients with chronic conditions across the United States with nationwide clinic expansion. Founded in 1999 and headquartered in Winter Park, Florida, the company formerly known as PivX Solutions Inc. changed its name in May 2004. Recent developments include the acquisition of Biolete to enter the functional beverage market; a strategic partnership with Cement Factory Nutrition co-owned by former WWE wrestler Jeff Sciullo to diversify supplements; a $500,000 line of credit from CEO Larry Powalisz for aHSCT clinic growth; partnerships with Aetna (effective July 2025) and pending United Healthcare inclusion to access millions of insured patients for regenerative therapies; a request to update its SIC code to 2836 for biological products reflecting stem cell and biologic advancements; filing of a patent application for regenerative medicine protocols via AdiaLabs LLC; and rapid sales force tripling for U.S. and global expansion.
Company News
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half
Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
Adia Med Finds Another Unicorn
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)